Finance Why Is Prothena Stock Trading Lower On Tuesday?May 27, 20250 Prothena Company plc (NASDAQ:PRTA) launched knowledge from the Part 3 AFFIRM-AL scientific trial evaluating birtamimab in sufferers with AL amyloidosis…
